Get started
Canadian Natural resources is undervaluedUsing my simple method of technical analysis and fundamental calculation of the intrinsic value of a stock for which the range of intrinsic value of CNQ is between $35-$55. Assuming oil can make a reversal at this pivotal time in history for the world the stock looks very cheap. It also pays good dividends soon which was a bonus I bought some at $31 dollars for the market price. It looks like a great addition to make a nicely diversified portfolio.
NYSE:CNQLong
by Capitalist_Zach
Broadcom - This was just the first all time high!Broadcom - NASDAQ:AVGO - just created new highs: (click chart above to see the in depth analysis👆🏻) Over the course of the past three months, Broadcom has been rallying an impressive +80%. However looking at market structure, all of the previous "dump and pump" was not unexpected. Following this recent bullish strength, Broadcom is likely to channel a lot higher. Levels to watch: $250, $400 Keep your long term vision! Philip (BasicTrading)
NASDAQ:AVGOLong
by basictradingtv
1
AVGO is always an easy decision for me -- long at 246.86 In addition to being at the heart of AI and having margins north of 70%, AVGO has done incredibly well with my algo. 381-0 with an average return of 1.71% in an average of 7 days - a .244% per day return, about 4x the average daily market return. However, adding the new filter I've been using ups that number dramatically. In the last 2 years, in 39 trades, it's 39-0 with an average return of 2.24% and an average of 3.6 days held. That's .63% per day or almost 15x the daily average return of the market. Only 6 of those 39 trades took more than one week to close and none took longer than a month. Only 10 of them made less than 1% and 7 made more than 4%. Combined with the fundamentals, the uptrend it's in, and the fact that it's sitting right on support makes the reward to risk ratio VERY high for me. The exit strategy Is FPC if the return is large enough, but not necessarily a FPC. As always - this is intended as "edutainment" and my perspective on what I am or would be doing, not a recommendation for you to buy or sell. Act accordingly and invest at your own risk. DYOR and only make investments that make good financial sense for you in your current situation.
NASDAQ:AVGOLong
by redwingcoach
5
ADM 1D: 10-Month Channel Says Goodbye?Since July 18, 2024, ADM had been locked in a clean downward channel — well-behaved, well-respected. But in May 2025, the structure finally cracked: price broke out, crossed above the 50-day MA, and pulled back for a textbook retest right on the channel’s upper edge. So far, the breakout is holding. The next targets sit at 50.6 (0.618), 53.5 (0.5), and 56.5 (0.382). As long as price stays outside the channel, the bullish structure remains intact. Connor’s RSI down below is quietly doing its job — already bounced from deep oversold, now curling up with momentum. It’s not flashy, but in this context it signals early strength before the crowd notices. Fundamentally, ADM is still cleaning up after the early-2024 accounting scandal that nuked investor trust. But management moved fast: reinstated buybacks, tightened guidance, and Q1 2025 came in strong — $22.6B revenue, $0.88 EPS, both beating expectations. ADM remains a pillar of the U.S. ag sector, and in an era of global food anxiety, that means structural demand isn’t going anywhere. Вот адаптированный перевод финального блока под **английский пост**, в том же живом и профессиональном стиле: Enjoyed the idea? Like, share, and drop your thoughts in the comments. It helps keep the content visible, free, and accessible to everyone. Got your own charts or takes? Let’s discuss them below.
NYSE:ADMLong
by TotoshkaTrades
Just Crazy Thoughts of Crazy GainsStock showing Buying Power recent days. Each Take Profit Line is where you may secure profit and run. Re-testing the Green Zone 4H with Buyers Step-in is perfect. Maybe we may not re-test it current price close at Support Level if it held for next session. I believe we will see Gains of 500-1000%. Each Line acts as Resistance level that worth watching with 15 TF in case any selling pressure secure profit is priority. Note: 1- Potentional of Strong Buying Zone: We have two scenarios must happen at The Mentioned Zone: Scenarios One: strong buying volume with reversal Candle. Scenarios Two: Fake Break-Out of The Buying Zone. Both indicate buyers stepping in strongly. NEVER Join in unless one showed up. 2- How to Buy Stock: On 15M TF when Marubozu Candle show up which indicate strong buyers stepping-in. Buy on 0.5 Fibo Level of the Marubozu Candle, because price will always and always re-test the imbalance.
NYSE:STEM
by Faisalzor
Amd - This starts the next +200% rally!Amd - NASDAQ:AMD - is preparing a major rally: (click chart above to see the in depth analysis👆🏻) It has - once again - not been unexpected at all that we now see a major reversal rally on Amd. After the harsh drop of about -65%, Amd retested a significant confluence of support and already created bullish confirmation. It is quite likely that this now starts the next bullrun. Levels to watch: $100, $300 Keep your long term vision! Philip (BasicTrading)
NASDAQ:AMDLong
by basictradingtv
23
Is NVDA Building Strength Before a Breakout?After cooling off from its $150 highs, NVIDIA (NVDA) is consolidating in the $140–$145 zone. While some traders fear the AI hype has peaked, others see this as the calm before another rally. With solid fundamentals, continued leadership in AI, and strong institutional backing, NVDA remains a name to watch closely. 🎯 Trade Setup: Entry Points ✅ $142 – Current price zone (speculative buy) ✅ $135–$130 – Strong support (ideal swing entry) ✅ $125 (only if market-wide pullback occurs) Profit Targets 📈 TP1: $149 – All-time high retest 🚀 TP2: $160 – Extension target 💰 TP3: $175+ – Long-term bullish scenario if momentum returns 💡 Strategy: This is a “buy-the-dip, trade-the-breakout” setup. Wait for confirmation above $146 if you're conservative, or accumulate gradually into weakness with a clear risk plan. 📌 Disclaimer: This is not financial advice. Always do your own research and use proper risk management. I'm sharing my personal view for educational purposes.
NASDAQ:NVDALong
by Robert_V12
Ironwood Pharmaceuticals | IRWD | Long at $0.61Ironwood Pharma NASDAQ:IRWD stock dropped ~89% in the past year due to disappointing Phase 3 Apraglutide trial results, FDA requiring an additional trial, weak Q1 2025 earnings (-$0.14 EPS vs. -$0.04 expected), high debt ($599.48M), and analyst downgrades. So why would I be interested in swing trading this company? The chart. The price has entered my "crash" simple moving average zone, which often results in a reversal - even if temporary. Also, Linzess (GI drug) revenue is steady, and I thoroughly believe that alone pushes the fair value near $0.95, if not higher. Thus, at $0.61, NASDAQ:IRWD is in a personal buy zone with the potential for additional declines before future rise. Target: $0.95 (+55.7%)
NASDAQ:IRWDLong
by WorthlessViews
WALMART testing its 1D MA50! Will it bounce?Walmart (WMT) hit yesterday its 1D MA50 (blue trend-line) for the first time since April 21. It appears that the rebound from the Trade War Low has turned sideways on a Double Top formation and the 1D MA50 is the first Support to be tested, with the 1D MA200 (orange trend-line) following. This pattern resembles the August - September 2022 Bull Flag, which despite breaking below its 1D MA50, it resumed the uptrend shortly after and hit the 1.382 Fibonacci extension before the next 1D MA50 pull-back. As a result, we expect the stock to reach $110.00 (Fib 1.382) by the end of the Summer. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:WMT
by TradingShot
Meta Platforms - This stock tastes sooo good!Meta Platforms - NASDAQ:META - will print a new all time high: (click chart above to see the in depth analysis👆🏻) Over the course of the past two months, Meta has been rallying +40%. This recent behaviour was not unexpected at all but rather the consequence of the all time high break and retest. Now - back at the previous all time high - Meta will most likely break out higher again. Levels to watch: $700, $900 Keep your long term vision! Philip (BasicTrading)
NASDAQ:METALong
by basictradingtv
4
California Resources Corporation (CRC) – Stock Analysis and ForeCalifornia Resources Corporation, a key player in crude oil production and carbon management, has recently experienced a notable uptick in investor interest. This momentum appears to be supported by macroeconomic tailwinds, including renewed trade tensions between the United States and other major economies. Historically, geopolitical uncertainty often leads to increased energy demand and price volatility, both of which tend to benefit domestic oil producers like CRC. From a fundamental standpoint, investor sentiment toward CRC has grown increasingly positive. The company’s strategic positioning in California's energy transition—particularly its focus on carbon capture and storage (CCS)—is beginning to resonate more with institutional investors looking to align portfolios with sustainable yet profitable energy operations. If these supportive fundamentals continue, there is potential for the stock to reach $56 in the coming months, assuming no major changes to current market dynamics or geopolitical influences. Technical Outlook: Entry Point: $44.68 Stop Loss: $42.73 Take Profit 1: $50.84 Take Profit 2: $55.88 As always, trade with care, apply proper risk management, and ensure your positions align with your overall investment strategy. If you find this helpful, kindly follow me, subscribe, like, comment and share.
NYSE:CRCLong
by ForexClinik
2
MSFT Surges to Record High, Sustaining Bullish MomentumMicrosoft (MSFT) has demonstrated remarkable resilience, fully recovering from losses incurred during the tariff war sell-off. The stock has even achieved a new all-time high. This performance underscores the stock’s persistent bullish trend. The low recorded on April 7, 2025 likely serves as a robust support level during future pullbacks. The rally from this low is unfolding as a classic five-wave impulse pattern, indicative of strong upward momentum, with wave (3) nearing completion. From the April 7 low, wave (1) concluded at 394.65, followed by a pullback in wave (2) that bottomed at 355.67. Wave (3) has since extended higher, exhibiting its own internal impulse structure. Within wave (3), wave 1 peaked at 380.39, with wave 2 dipping to 375.19. The stock then surged in wave 3 to 459.58, followed by a wave 4 retracement ending at 448.91. A detailed 45-minute chart below highlights the final leg wave 5, which further subdivides into a lesser-degree impulse. From wave 4, wave ((i)) reached 463 and wave ((ii)) corrected to 454. Wave ((iii)) climbed to 473.43, and wave ((iv)) dipped to 466.96. MSFT may experience a slight further upside to complete wave ((v)) of 5 of (3). However, a larger-degree pullback in wave (4) is anticipated soon, setting the stage for one final upward push to conclude the five-wave rally from the April 7 low. This structured advance reinforces Microsoft’s bullish outlook, with key support levels likely to hold firm.
NASDAQ:MSFT
by Elliottwave-Forecast
Where is HIMS set to go next?Overview of Hims & Hers Health (NYSE: HIMS): Pros Expanding into weight-loss treatments -Hims successfully entered the high-demand GLP‑1 weight-loss space by selling compounded semaglutide during shortages. With branded Wegovy now available on their platform in partnership with Novo Nordisk, they’ve broadened their offering. Solid growth & rising profitability -Revenue surged ~18% in 2024 to $1.78 b ttm, with annual net income of $164 m. -Q1 2025 reported >100% YoY revenue growth ($586 m) with expected profit of 20¢/share. Strong gross margins -At around 80–88%, comparable to peer telehealth platforms. Diverse healthcare offerings -Beyond weight loss: sexual health, skincare, hair loss, mental health via DTC model. Expanded further via European acquisition of ZAVA (~1.3 m subscribers). Undervalued relative to future earnings -Analysts project 2030 revenues of $6.5 b—implying mid‑20s% CAGR. With projected EPS ~$1.5 b, current multiples (P/E ~40x) might look reasonable long term. Cons GLP‑1 strategy under pressure -The end of compounding allowances by FDA reduced their low-cost advantage. -Dependence on cash-pay vs. insurer coverage may limit growth if insurers cap co-pays. High valuation with risk -Trading at ~84x trailing EPS and ~70x forward EPS—wide margin for missteps. -Analysts average target at $38 (≈ 33% downside), 12 rate it a 'Hold'. Competitive & regulatory headwinds -Market crowded with telehealth players like Ro, Noom, CVS, and insurers which may undercut cash-pay model. -Legal scrutiny over “personalized” compounded products persists; Novo lawsuits underway. Reputation & controversy -CEO’s political donation stirred backlash; regulatory scrutiny around ads and compounding practices. -Platform has faced occasional service and customer trust issues. -Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, investment recommendation, or an offer to buy or sell any securities. Stock prices, valuations, and performance metrics are subject to change and may be outdated. Always conduct your own due diligence and consult with a licensed financial advisor before making investment decisions. The information presented may contain inaccuracies and should not be solely relied upon for financial decisions. I am not personally liable for your own losses, this is not financial advise.
NYSE:HIMS
by bossout10
1
What's going on with $OSCR? Let's break it down!🚨 What's going on with NYSE:OSCR ? Let's break it down! 👇 📌 Long-term investors: Every dip = buy/add opportunity 📌 Traders: Short term, we may fill the $13.31 GAP 🔹 Massive volume shelf & consolidation between $11-$17 for nearly 2 years—the bigger the base, the bigger the breakout! 🔹 Rising trendline since April lows—if this breaks, expect a move to $13.31 GAP, possibly $11-$12. Strong support here unless bad news or a market correction hits. 🔹 Break above $18.27 (earnings pop) = 🚀 $20+ short term 🔹 200DMA rejection after retest from below = bearish short term 🔹 WR% is making a lower low instead of swinging higher—watching this closely. 🧐 Overall: We’re in a consolidation phase—when it moves, expect it to be quick & explosive 🔥 Best strategy: DCA & wait for the inevitable surge to $20+ (barring major setbacks). Stay patient. Stay focused. NYSE:OSCR ’s move is coming! 💪
NYSE:OSCRLong
by RonnieV29